- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNAs in Cancer Treatment-Induced Cardiotoxicity
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 3, Pages 704
Publisher
MDPI AG
Online
2020-03-19
DOI
10.3390/cancers12030704
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-499-5p Attenuates Mitochondrial Fission and Cell Apoptosis via p21 in Doxorubicin Cardiotoxicity
- (2019) Qinggong Wan et al. Frontiers in Genetics
- Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity
- (2019) Giuseppina Milano et al. CARDIOVASCULAR RESEARCH
- Current status of nanomedicine in the chemotherapy of breast cancer
- (2019) A. I. Fraguas-Sánchez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
- (2019) Maya Guglin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a, -155, -221 and -222 in blood of women with breast cancer
- (2019) Roser Esplugas et al. PLoS One
- miR-34b/c regulates doxorubicin-induced myocardial cell injury through ITCH
- (2019) Wen-Cai Zhang et al. CELL CYCLE
- miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice
- (2019) Xiaoping Hu et al. Oxidative Medicine and Cellular Longevity
- Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients
- (2018) Pierre Frères et al. BMC CANCER
- Serum miR-30c Level Predicted Cardiotoxicity in Non-small Cell Lung Cancer Patients Treated with Bevacizumab
- (2018) Fang Zhou et al. Cardiovascular Toxicology
- MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity
- (2018) Xibo Jing et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Mechanism of cardiovascular toxicity by proteasome inhibitors: New paradigm derived from clinical and pre-clinical evidence
- (2018) Mara Gavazzoni et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy
- (2018) Jiajia Xi et al. ONCOGENE
- Prevalence and incidence of psoriatic arthritis: A systematic review and meta-analysis
- (2018) Lorenza Scotti et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Macrophage migration inhibitory factor serves a pivotal role in�the regulation of radiation-induced cardiac senescencethrough rebalancing the microRNA-34a/sirtuin 1 signaling pathway
- (2018) Yiwang Hu et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Association between miR-21/146a/155 level changes and acute genitourinary radiotoxicity in prostate cancer patients: A pilot study
- (2018) Katarina Kopcalic et al. PATHOLOGY RESEARCH AND PRACTICE
- MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload–Induced Heart FailureNovelty and Significance
- (2017) Robin Verjans et al. HYPERTENSION
- Cardiovascular Complications of Cancer Therapy
- (2017) Hui-Ming Chang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- MiRNA-30e mediated cardioprotection of ACE2 in rats with Doxorubicin-induced heart failure through inhibiting cardiomyocytes autophagy
- (2017) Lei Lai et al. LIFE SCIENCES
- Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights
- (2017) Ping-Pin Zheng et al. MEDICINAL RESEARCH REVIEWS
- Doxorubicin upregulates CXCR4 via miR-200c/ZEB1-dependent mechanism in human cardiac mesenchymal progenitor cells
- (2017) Sara Beji et al. Cell Death & Disease
- Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patients
- (2017) Verena Lieb et al. Oncotarget
- Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity
- (2017) Jie-Ning Zhu et al. Scientific Reports
- Circulating microRNAs: Potential Markers of Cardiotoxicity in Children and Young Adults Treated With Anthracycline Chemotherapy
- (2017) Kasey J. Leger et al. Journal of the American Heart Association
- Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions
- (2017) Diwakar Jain et al. Current Cardiology Reports
- From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview
- (2017) Carlo Gabriele Tocchetti et al. ANTIOXIDANTS & REDOX SIGNALING
- miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway
- (2016) Zhongwei Yin et al. Aging-US
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane
- (2016) Olga Lenčová-Popelová et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cardiac cytochrome c and cardiolipin depletion during anthracycline-induced chronic depression of mitochondrial function
- (2016) Gonçalo C. Pereira et al. MITOCHONDRION
- Combination chemoprevention with grape antioxidants
- (2016) Chandra K. Singh et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer
- (2016) Tru-Khang T. Dinh et al. Radiation Oncology
- Inhibition of chymotryptic-like standard proteasome activity exacerbates doxorubicin-induced cytotoxicity in primary cardiomyocytes
- (2016) Eva-Margarete Spur et al. TOXICOLOGY
- MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat
- (2016) Elena Piegari et al. Oncotarget
- Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients
- (2016) Vagner Oliveira-Carvalho Rigaud et al. Oncotarget
- Drug-induced mitochondrial dysfunction and cardiotoxicity
- (2015) Zoltán V Varga et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The Adverse Effects of Sorafenib in Patients with Advanced Cancers
- (2015) Ye Li et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure
- (2015) Chris J. Watson et al. EUROPEAN JOURNAL OF HEART FAILURE
- MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2
- (2015) Zhongyi Tong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating mir-208a fails as a biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients
- (2015) Vagner Oliveira-Carvalho et al. JOURNAL OF APPLIED TOXICOLOGY
- Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
- (2015) Javid J. Moslehi et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction
- (2015) Hasahya Tony et al. Oxidative Medicine and Cellular Longevity
- Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis
- (2015) L Roca-Alonso et al. Cell Death & Disease
- Non-coding RNAs in cardiac regeneration
- (2015) Lichan Tao et al. Oncotarget
- Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors
- (2015) Amy A. Kirkham et al. Journal of Oncology
- Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153
- (2015) Babak Baban et al. PLoS One
- MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis
- (2014) M Su et al. CELL DEATH AND DIFFERENTIATION
- The Effect of Radiation on the Immune Response to Cancers
- (2014) Bonggoo Park et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Plasma miR-208 as a useful biomarker for drug-induced cardiotoxicity in rats
- (2014) Yoko Nishimura et al. JOURNAL OF APPLIED TOXICOLOGY
- Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
- (2014) Yoshihiko Ichikawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Use of Myocardial Strain Imaging by Echocardiography for the Early Detection of Cardiotoxicity in Patients During and After Cancer Chemotherapy
- (2014) Paaladinesh Thavendiranathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Neuropilin Regulation of Angiogenesis, Arteriogenesis, and Vascular Permeability
- (2014) Alice Plein et al. MICROCIRCULATION
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
- (2014) Tomáš Šimůnek et al. Pharmacological Reports
- MicroRNAs as Therapeutic Targets and Biomarkers of Cardiovascular Disease
- (2014) E. N. Olson Science Translational Medicine
- Early biomarkers of doxorubicin-induced heart injury in a mouse model
- (2014) Varsha G. Desai et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Doxorubicin induces senescence and impairs function of human cardiac progenitor cells
- (2013) Elena Piegari et al. BASIC RESEARCH IN CARDIOLOGY
- An Engineered Bivalent Neuregulin Protects Against Doxorubicin-Induced Cardiotoxicity With Reduced Proneoplastic Potential
- (2013) Steven M. Jay et al. CIRCULATION
- Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic Cardiomyopathy
- (2013) Roberta Roncarati et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Intralesional bevacizumab as in-add adjuvant to immunocryosurgery for locally advanced basal cell carcinoma
- (2013) G. Gaitanis et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Cancer drugs and the heart: importance and management
- (2012) T. M. Suter et al. EUROPEAN HEART JOURNAL
- Platinum and anthracycline therapy for advanced cutaneous squamous cell carcinoma
- (2012) Kenta Nakamura et al. International Journal of Clinical Oncology
- MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression
- (2012) Changxin Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Screening Adult Survivors of Childhood Cancer for Cardiomyopathy: Comparison of Echocardiography and Cardiac Magnetic Resonance Imaging
- (2012) Gregory T. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis
- (2012) M. L. Tarrio et al. JOURNAL OF IMMUNOLOGY
- The Usefulness of Brain Natriuretic Peptide in Complex Congenital Heart Disease
- (2012) Jannet A. Eindhoven et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
- (2012) E. J. A. Bowles et al. JNCI-Journal of the National Cancer Institute
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Perturbation of microRNAs in Rat Heart during Chronic Doxorubicin Treatment
- (2012) Caterina Vacchi-Suzzi et al. PLoS One
- miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition
- (2011) A Magenta et al. CELL DEATH AND DIFFERENTIATION
- Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer
- (2011) Jessica M. Scott et al. CIRCULATION
- Repression of P66Shc Expression by SIRT1 Contributes to the Prevention of Hyperglycemia-Induced Endothelial Dysfunction
- (2011) Shuang Zhou et al. CIRCULATION RESEARCH
- Relationship Between the Temporal Profile of Plasma microRNA and Left Ventricular Remodeling in Patients After Myocardial Infarction
- (2011) Michael R. Zile et al. Circulation-Cardiovascular Genetics
- miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
- (2011) M. Garofalo et al. CURRENT MOLECULAR MEDICINE
- Cell-specific effects of miR-221/222 in vessels: Molecular mechanism and therapeutic application
- (2011) Xiaojun Liu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
- (2011) Thomas Force et al. NATURE REVIEWS DRUG DISCOVERY
- Gene silencing by microRNAs: contributions of translational repression and mRNA decay
- (2011) Eric Huntzinger et al. NATURE REVIEWS GENETICS
- Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials
- (2010) Vishal Ranpura et al. ACTA ONCOLOGICA
- Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes
- (2010) F. A. B. Schutz et al. ANNALS OF ONCOLOGY
- Combined Treatment With Rituximab and Anthracycline-Containing Chemotherapy for Primary Cutaneous Large B-Cell Lymphomas, Leg Type, in Elderly Patients
- (2010) Alexis Guyot et al. ARCHIVES OF DERMATOLOGY
- Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
- (2010) Lesley A Smith et al. BMC CANCER
- Emerging roles of SIRT1 in vascular endothelial homeostasis
- (2010) Michael Potente et al. CELL CYCLE
- A translational study of circulating cell-free microRNA-1 in acute myocardial infarction
- (2010) Yunhui Cheng et al. CLINICAL SCIENCE
- The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer?
- (2010) Simone Brabletz et al. EMBO REPORTS
- Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses
- (2010) Andrew Jabbour et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2010) Thomas Eschenhagen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Renal Medullary MicroRNAs in Dahl Salt-Sensitive Rats
- (2010) Yong Liu et al. HYPERTENSION
- MicroRNAs: Redefining Mechanisms in Cardiac Disease
- (2010) Gerald W Dorn JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Cardiomyocyte PDGFR-β signaling is an essential component of the mouse cardiac response to load-induced stress
- (2010) Vishnu Chintalgattu et al. JOURNAL OF CLINICAL INVESTIGATION
- Troponin I Provides Insight Into Cardiotoxicity and the Anthracycline-Trastuzumab Interaction
- (2010) Michael S. Ewer et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
- (2010) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure
- (2010) Runlin Gao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
- (2010) Michael S. Ewer et al. Nature Reviews Cardiology
- Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction
- (2009) Zhi-Xin Shan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection
- (2009) Yanjie Lu et al. CARDIOVASCULAR RESEARCH
- MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue
- (2009) Sashwati Roy et al. CARDIOVASCULAR RESEARCH
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- A Novel Role of MicroRNA in Late Preconditioning
- (2009) Chang Yin et al. CIRCULATION RESEARCH
- Plasma miR-208 as a Biomarker of Myocardial Injury
- (2009) X. Ji et al. CLINICAL CHEMISTRY
- MicroRNA-1 Regulates Cardiomyocyte Apoptosis by Targeting Bcl-2
- (2009) Yehua Tang et al. International Heart Journal
- MicroRNA Expression Signature and the Role of MicroRNA-21 in the Early Phase of Acute Myocardial Infarction
- (2009) Shimin Dong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Many roads to maturity: microRNA biogenesis pathways and their regulation
- (2009) Julia Winter et al. NATURE CELL BIOLOGY
- Ionizing Radiation-Induced Oxidative Stress Alters miRNA Expression
- (2009) Nicole L. Simone et al. PLoS One
- Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart
- (2008) Filomena de Nigris et al. EUROPEAN JOURNAL OF CANCER
- NEW TECHNOLOGIES IN RADIATION THERAPY: ENSURING PATIENT SAFETY, RADIATION SAFETY AND REGULATORY ISSUES IN RADIATION ONCOLOGY
- (2008) Howard I. Amols HEALTH PHYSICS
- Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells
- (2008) L L Remsing Rix et al. LEUKEMIA
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
- (2008) Thomas Thum et al. NATURE
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
- (2008) E. van Rooij et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide
- (2006) J Damrot et al. BRITISH JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started